The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Reasoning
The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Cite this ruling
CBP Ruling N013396 (3004909185): The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Mycophenolate Motefil Injection, in dosage form, from India
The tariff classification of Satin Smooth Res-Q Topical Analgesic Soothing Gel and Satin Smooth Res-Q Analgesic Topical Pain Relief Spray from Canada
Application for Further Review of Protest No. 4601-13-100263; Tariff Classification of Rescue Remedy Gum
The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India